Follow us on :


Take a look at the recent articles

6-methoxy-8-[[6-methoxy-8-[[6-methoxy-2-methyl-1-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-yl]oxy]-2-methyl-1-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-yl]oxy]-2-methyl-1-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-ol time-resolved absorption and resonance ft-ir and raman biospectroscopy and density functional theory (dft) investigation of vibronic-mode coupling structure in vibrational spectra analysis

Alireza Heidari

Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA

American International Standards Institute, Irvine, CA 3800, USA

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Jennifer Esposito

Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA

Angela Caissutti

Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA

DOI: 10.15761/CCSR.1000126

Article
Article Info
Author Info
Figures & Data

Abstract

A macromolecule is a very large molecule, such as protein, commonly created by the polymerization of smaller subunits (monomers). They are typically composed of thousands of atoms or more. The most common macromolecules in biochemistry are biopolymers (nucleic acids, proteins, carbohydrates and lipids) and large non-polymeric molecules (such as lipids and macrocycles). Synthetic macromolecules include common plastics and synthetic fibers as well as experimental materials such as carbon nanotubes. Parameters such as FT­-IR and Raman vibrational wavelengths and intensities for single crystal 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4- Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol are calculated using density functional theory and were compared with empirical results. The investigation about vibrational spectrum of cycle dimers in crystal with carboxyl groups from each molecule of acid was shown that it leads to create Hydrogen bonds for adjacent molecules. The current study aimed to investigate the possibility of simulating the empirical values. Analysis of vibrational spectrum of 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol is performed based on theoretical simulation and FT-IR empirical spectrum and Raman empirical spectrum using density functional theory in levels of HF/6-31G*, HF/6-31++G**, MP2/6-31G, MP2/6-31++G**, BLYP/6-31G, BLYP/6-31++G**, B3LYP/6-31G and B3LYP6-31-HEG**. Vibration modes of methylene, carboxyl acid and phenyl cycle are separately investigated. The obtained values confirm high accuracy and validity of results obtained from calculations.

Molecular structure of a 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4- Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol [1-42].

Key words

vibronic structure, vibrational spectra, density functional theory (dft), 6-methoxy-8-[[6-methoxy-8-[[6-methoxy-2-methyl-1-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-yl]oxy]-2-methyl-1-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-yl]oxy]-2-methyl-1-(2-methylpropyl)-3,4-dihydro-1h-isoquinolin-7-ol,time-resolved resonance, ft-ir and raman spectroscopy

Introduction

A macromolecule is a very large molecule, such as protein, commonly created by the polymerization of smaller subunits (monomers). They are typically composed of thousands of atoms or more. The most common macromolecules in biochemistry are biopolymers (nucleic acids, proteins, carbohydrates and lipids) and large non-polymeric molecules (such as lipids and macrocycles). Synthetic macromolecules include common plastics and synthetic fibers as well as experimental materials such as carbon nanotubes. Density Functional Theory (DFT) is one of the most powerful calculation methods for electronic structures [5-7]. Numerous results have been previously studied and indicate successful use of these methods [8-10]. The theory is one of the most appropriate methods for simulating the vibrational wavenumbers, molecular structure as well as total energy. It may be useful to initially consider the calculated results by density functional theory using HF/6-31G*, HF/6-31++G**, MP2/6-31G, MP2/6-31++G**, BLYP/6-31G, BLYP/6-31++G**, B3LYP/6-31G and B3LYP6-31-HEG** approach [11-16]. It should be noted that calculations are performed by considering one degree of quantum interference as well as polarization effects of 2d orbitals in interaction [17-364].

Details of Calculations

All calculations of molecular orbital in the base of ab are performed by Gaussian 09. In calculation process, the structure of 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4- Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol molecule (Figure 1) is optimized and FT-IR and Raman wavenumbers are calculated using HF/6-31G*, HF/6-31++G**, MP2/6-31G, MP2/6-31++G**, BLYP/6-31G, BLYP/6-31++G**, B3LYP/6-31G and B3LYP6-31-HEG** base. All optimized structures are adjusted with minimum energy. Harmonic vibrational wavenumbers are calculated using second degree of derivation to adjust convergence on potential surface as good as possible and to evaluate vibrational energies at zero point. In optimized structures considered in the current study, virtual frequency modes are not observed which indicates that the minimum potential energy surface is correctly chosen. The optimized geometry is calculated by minimizing the energy relative to all geometrical quantities without forcing any constraint on molecular symmetry. Calculations were performed by Gaussian 09. The current calculation is aimed to maximize structural optimization using density functional theory. The calculations of density functional theory are performed by HF/6-31G*, HF/6-31++G**, MP2/6-31G, MP2/6-31++G**, BLYP/6-31G, BLYP/6-31++G**, B3LYP/6-31G and B3LYP6-31-HEG** function in which non-focal functions of Becke and correlation functions of Lee-Yang-Parr beyond the Franck-Condon approximation are used. After completion of optimization process, the second order derivation of energy is calculated as a function of core coordination and is investigated to evaluate whether the structure is accurately minimized. Vibrational frequencies used to simulate spectrums presented in the current study are derived from these second order derivatives. All calculations are performed for room temperature of 508 (K).

Figure 1. Different sections of the extensive two-dimensional hydrogen bond network in a 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4- Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol [43-93]

Vibration Analysis

Analysis of vibrational spectrum of 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol is performed based on theoretical simulation and FT-IR empirical spectrum and Raman empirical spectrum using density functional theory in levels of HF/6-31G*, HF/6-31++G**, MP2/6-31G, MP2/6-31++G**, BLYP/6-31G, BLYP/6-31++G**, B3LYP/6-31G and B3LYP6-31-HEG**. Vibration modes of methylene, carboxyl acid and phenyl cycle are separately investigated.

C-H stretching vibrations in single replacement of benzene cycles are usually seen in band range of 3000-4000 cm-1. Weak Raman bands are at 3193 cm-1 and 3207 cm-1. C-C stretching mode is a strong Raman mode at 1211cm-1. Raman weak band is seen at 1667 cm-1, too. Bending mode of C-H is emerged as a weak mode at 1388 cm-1 and 1187 cm-1 and a strong band at 1291 cm-1 in Raman spectrum. Raman is considerably active in the range of 1000-2000 cm-1 which 1189 cm-1 indicates this issue.

C-H skew-symmetric stretching mode of methylene group is expected at 3199 cm-1 and its symmetric mode is expected at 3001 cm-1. Skew-symmetric stretching mode of CH2 in 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4- Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol has a mode in mid-range of Raman spectrum at 3000-3530 cm-1. When this mode is symmetric, it is at 3098 cm-1 and is sharp. The calculated wavenumbers of higher modes are at 3064 cm-1 and 3098 cm-1 for symmetric and skew-symmetric stretching mode of methylene, respectively.

Scissoring vibrations of CH2 are usually seen at the range of 1528-1589 cm-1 which often includes mid-range bands. Weak bands at 1555 cm-1 are scissoring modes of CH2 in Raman spectrum. Moving vibrations of methylene are usually seen at 1473 cm-1. For the investigated chemical in the current study, these vibrations are at 1341 cm-1 were calculated using density functional theory. Twisting and rocking vibrations of CH2 are seen in Raman spectrum at 900 cm-1 and 1200 cm-1, respectively, which are in good accordance with the results at 915 cm-1 and 1185 cm-1, respectively.

In a non-ionized carboxyl group (COOH), stretching vibrations of carbonyl [C=O] are mainly observed at the range of 1880-11890 cm-1. If dimer is considered as an intact constituent, two stretching vibrations of carbonyl for symmetric stretching are at 1765-1795 cm-1 in Raman spectrum. In the current paper, stretching vibration of carbonyl mode is at 1803 cm-1 which is a mid-range value.

Stretching and bending bands of hydroxyl can be identified by width and band intensity which in turn is dependent on bond length of Hydrogen. In dimer form of Hydrogen bond, stretching band of O-H is of a strong Raman peak at 1387 cm-1 which is due to in-plain metamorphosis mode. Out-of-plain mode of O-H group is a very strong mode of peak at 1056 cm-1 of Raman spectrum. The stretching mode of C-O (H) emerges as a mid-band of Raman spectrum at 1267 cm-1.

Lattice vibrations are usually seen at the range of 0-800 cm-1. These modes are induced by rotary and transferring vibrations of molecules and vibrations and are including Hydrogen bond. Bands with low wavenumbers of Hydrogen bond vibrations in FT-IR and Raman spectrum (Figure 2) are frequently weak, width and unsymmetrical. Rotary lattice vibrations are frequently stronger than transferring ones. Intra-molecular vibrations with low wavenumbers involving two-bands O-H …O dimer at 89 cm-1, 196 cm-1 and 259 cm-1 are attributed to a rotary moving of two molecules involving in-plain rotation of molecules against each other.

Figure 2. 3D Simulation of (a) FT-IR spectrum and (b) Raman spectrum of 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol

Conclusion and Summary

Calculations of density functional theory using HF/6-31G*, HF/6-31++G**, MP2/6-31G, MP2/6-31++G**, BLYP/6-31G, BLYP/6-31++G**, B3LYP/6-31G and B3LYP6-31-HEG** levels were used to obtain vibrational wavenumbers and intensities in single crystal of 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol. Investigation and consideration of vibrational spectrum confirm the formation of dimer cycles in the investigated crystal with carboxyl groups from each Hydrogen molecule of acid protected from adjacent molecules. The calculated vibrational spectrum which obtains from calculations of density functional theory is in good accordance with recorded empirical values which indicates successful simulation of the problem. The obtained results indicate that the results obtained from theoretical calculations are valid through comparing with empirical recorded results.

Acknowledgements

Authors are supported by an American International Standards Institute (AISI) Future Fellowship Grant FT1363001328979. We acknowledge Ms. Isabelle Villena for instrumental support and Dr. Michael N. Cocchi for constructing graphical abstract figure. We gratefully acknowledge Prof. Dr. Christopher Brown for proofreading the manuscript.

References

  1. Yu, P.; Wu, J.; Liu, S.; Xiong, J.; Jagadish, C.; Wang, Z. M.Design and Fabrication of Silicon Nanowires towards Efficient Solar Cells. Nano Today2016, 11, 704–737, 10.1016/j.nantod.2016.10.001
  2. Sandhu, S.; Fan, S.Current-Voltage Enhancement of a Single Coaxial Nanowire Solar Cell. ACS Photonics2015, 2, 1698–1704, 10.1021/acsphotonics.5b00236
  3. van Dam, D.; Van Hoof, N. J. J.; Cui, Y.; van Veldhoven, P. J.; Bakkers, E. P. A. M.; Gómez Rivas, J.; Haverkort, J. E. M.High-Efficiency Nanowire Solar Cells with Omnidirectionally Enhanced Absorption Due to Self-Aligned Indium-Tin-Oxide Mie Scatterers. ACS Nano2016, 10, 11414–11419, 10.1021/acsnano.6b06874
  4. Luo, S.; Yu, W. B.; He, Y.; Ouyang, G.Size-Dependent Optical Absorption Modulation of Si/Ge and Ge/Si Core/shell Nanowires with Different Cross-Sectional Geometries. Nanotechnology2015, 26, 085702, 10.1088/0957-4484/26/8/085702
  5. Yu, P.; Yao, Y.; Wu, J.; Niu, X.; Rogach, A. L.; Wang, Z.Effects of Plasmonic Metal Core-Dielectric Shell Nanoparticles on the Broadband Light Absorption Enhancement in Thin Film Solar Cells. Sci. Rep.2017, 7, 7696, 10.1038/s41598-017-08077-9
  6. Gouda, A. M.; Allam, N. K.; Swillam, M. A.Efficient Fabrication Methodology of Wide Angle Black Silicon for Energy Harvesting Applications. RSC Adv.2017, 7, 26974–26982, 10.1039/C7RA03568C
  7. Branz, H. M.; Yost, V. E.; Ward, S.; Jones, K. M.; To, B.; Stradins, P.Nanostructured Black Silicon and the Optical Reflectance of Graded-Density Surfaces. Appl. Phys. Lett.2009, 94, 231121, 10.1063/1.3152244
  8. Fazio, B.; Artoni, P.; Antonía Iatí, M.; D’Andrea, C.; Lo Faro, M. J.; Del Sorbo, S.; Pirotta, S.; Giuseppe Gucciardi, P.; Musumeci, P.; Salvatore Vasi, C.; Saija, R.; Galli, M.; Priolo, F.; Irrera, A.Strongly Enhanced Light Trapping in a Two-Dimensional Silicon Nanowire Random Fractal Array. Light: Sci. Appl.2016, 5, e16062, 10.1038/lsa.2016.62
  9. Ko, M.-D.; Rim, T.; Kim, K.; Meyyappan, M.; Baek, C.-K.High Efficiency Silicon Solar Cell Based on Asymmetric Nanowire. Sci. Rep.2015, 5, 11646, 10.1038/srep11646
  10. Oh, J.; Yuan, H. C.; Branz, H. M.An 18.2%-Efficient Black-Silicon Solar Cell Achieved through Control of Carrier Recombination in Nanostructures. Nat. Nanotechnol.2012, 7, 743–748, 10.1038/nnano.2012.166
  11. Lin, H.; Xiu, F.; Fang, M.; Yip, S.; Cheung, H. Y.; Wang, F.; Han, N.; Chan, K. S.; Wong, C. Y.; Ho, J. C.Rational Design of Inverted Nanopencil Arrays for Cost-Effective, Broadband, and Omnidirectional Light Harvesting. ACS Nano2014, 8, 3752–3760, 10.1021/nn500418x
  12. Garnett, E.; Yang, P.Light Trapping in Silicon Nanowire Solar Cells. Nano Lett.2010, 10, 1082–1087, 10.1021/nl100161z
  13. Misra, S.; Yu, L.; Foldyna, M.; Roca I Cabarrocas, P.High Efficiency and Stable Hydrogenated Amorphous Silicon Radial Junction Solar Cells Built on VLS-Grown Silicon Nanowires. Sol. Energy Mater. Sol. Cells2013, 118, 90–95, 10.1016/j.solmat.2013.07.036
  14. Kelzenberg, M. D.; Boettcher, S. W.; Petykiewicz, J. A.; Turner-Evans, D. B.; Putnam, M. C.; Warren, E. L.; Spurgeon, J. M.; Briggs, R. M.; Lewis, N. S.; Atwater, H. A.Enhanced Absorption and Carrier Collection in Si Wire Arrays for Photovoltaic Applications. Nat. Mater.2010, 9, 239–244, 10.1038/nmat2635
  15. Tian, B.; Zheng, X.; Kempa, T. J.; Fang, Y.; Yu, N.; Yu, G.; Huang, J.; Lieber, C. M.Coaxial Silicon Nanowires as Solar Cells and Nanoelectronic Power Sources. Nature2007, 449, 885–889, 10.1038/nature06181
  16. Razek, S. A.; Swillam, M. A.; Allam, N. K.Vertically Aligned Crystalline Silicon Nanowires with Controlled Diameters for Energy Conversion Applications: Experimental and Theoretical Insights. J. Appl. Phys.2014, 115, 194305, 10.1063/1.4876477
  17. Dhindsa, N.; Walia, J.; Saini, S. S.A Platform for Colorful Solar Cells with Enhanced Absorption. Nanotechnology2016, 27, 495203, 10.1088/0957-4484/27/49/495203
  18. Dhindsa, N.; Walia, J.; Pathirane, M.; Khodadad, I.; Wong, W. S.; Saini, S. S.Adjustable Optical Response of Amorphous Silicon Nanowires Integrated with Thin Films. Nanotechnology2016, 27, 145703, 10.1088/0957-4484/27/14/145703
  19. Zhu, J.; Yu, Z.; Burkhard, G. F.; Hsu, C.-M.; Connor, S. T.; Xu, Y.; Wang, Q.; McGehee, M.; Fan, S.; Cui, Y.Optical Absorption Enhancement in Amorphous Silicon Nanowire and Nanocone Arrays. Nano Lett.2009, 9, 279–282, 10.1021/nl802886y
  20. Klinger, D.; Łusakowska, E.; Zymierska, D.Nano-Structure Formed by Nanosecond Laser Annealing on Amorphous Si Surface. Mater. Sci. Semicond. Process.2006, 9, 323–326, 10.1016/j.mssp.2006.01.027
  21. Kumar, P.; Krishna, M. G.; Bhattacharya, A.Excimer Laser Induced Nanostructuring of Silicon Surfaces. J. Nanosci. Nanotechnol.2009, 9, 3224–3232, 10.1166/jnn.2009.207
  22. Kumar, P.Surface Modulation of Silicon Surface by Excimer Laser at Laser Fluence below Ablation Threshold. Appl. Phys. A: Mater. Sci. Process.2010, 99, 245–250, 10.1007/s00339-009-5510-x
  23. Adikaari, A. A. D. T.; Silva, S. R. P.Thickness Dependence of Properties of Excimer Laser Crystallized Nano-Polycrystalline Silicon. J. Appl. Phys.2005, 97, 114305, 10.1063/1.1898444
  24. Adikaari, A. A. D. T.; Dissanayake, D. M. N. M.; Hatton, R. A.; Silva, S. R. P.Efficient Laser Textured Nanocrystalline Silicon-Polymer Bilayer Solar Cells. Appl. Phys. Lett.2007, 90, 203514, 10.1063/1.2739365
  25. Adikaari, A. A. D. T.; Silva, S. R. P.Excimer Laser Crystallization and Nanostructuring of Amorphous Silicon for Photovoltaic Applications. Nano2008, 3, 117–126, 10.1142/S1793292008000915
  26. Tang, Y. F.; Silva, S. R. P.; Boskovic, B. O.; Shannon, J. M.; Rose, M. J.Electron Field Emission from Excimer Laser Crystallized Amorphous Silicon. Appl. Phys. Lett.2002, 80, 4154–4156, 10.1063/1.1482141
  27. Jin, S.; Hong, S.; Mativenga, M.; Kim, B.; Shin, H. H.; Park, J. K.; Kim, T. W.; Jang, J.Low Temperature Polycrystalline Silicon with Single Orientation on Glass by Blue Laser Annealing. Thin Solid Films2016, 616, 838–841, 10.1016/j.tsf.2016.10.026
  28. Crouch, C. H.; Carey, J. E.; Warrender, J. M.; Aziz, M. J.; Mazur, E.; Génin, F. Y.Comparison of Structure and Properties of Femtosecond and Nanosecond Laser-Structured Silicon. Appl. Phys. Lett.2004, 84, 1850–1852, 10.1063/1.1667004
  29. Wu, C.; Crouch, C. H.; Zhao, L.; Carey, J. E.; Younkin, R.; Levinson, J. A.; Mazur, E.; Farrell, R. M.; Gothoskar, P.; Karger, A.Near-Unity below-Band-Gap Absorption by Microstructured Silicon. Appl. Phys. Lett.2001, 78, 1850–1852, 10.1063/1.1358846
  30. Pedraza, A. J.; Fowlkes, J. D.; Lowndes, D. H.Silicon Microcolumn Arrays Grown by Nanosecond Pulsed-Excimer Laser Irradiation. Appl. Phys. Lett.1999, 74, 2322, 10.1063/1.123838
  31. edraza, A. J.; Fowlkes, J. D.; Jesse, S.; Mao, C.; Lowndes, D. H.Surface Micro-Structuring of Silicon by Excimer-Laser Irradiation in Reactive Atmospheres. Appl. Surf. Sci.2000, 168, 251–257, 10.1016/S0169-4332(0000611-5
  32. Porte, H. P.; Turchinovich, D.; Persheyev, S.; Fan, Y.; Rose, M. J.; Jepsen, P. U.On Ultrafast Photoconductivity Dynamics and Crystallinity of Black Silicon. IEEE Trans. Terahertz Sci. Technol.2013, 3, 331–341, 10.1109/TTHZ.2013.2255917
  33. Georgiev, D. G.; Baird, R. J.; Avrutsky, I.; Auner, G.; Newaz, G.Controllable Excimer-Laser Fabrication of Conical Nano-Tips on Silicon Thin Films. Appl. Phys. Lett.2004, 84, 4881–4883, 10.1063/1.1762978
  34. Eizenkop, J.; Avrutsky, I.; Georgiev, D. G.; Chaudchary, V.Single-Pulse Excimer Laser Nanostructuring of Silicon: A Heat Transfer Problem and Surface Morphology. J. Appl. Phys.2008, 103, 094311, 10.1063/1.2910196
  35. Eizenkop, J.; Avrutsky, I.; Auner, G.; Georgiev, D. G.; Chaudhary, V.Single Pulse Excimer Laser Nanostructuring of Thin Silicon Films: Nanosharp Cones Formation and a Heat Transfer Problem. J. Appl. Phys.2007, 101, 094301, 10.1063/1.2720185
  36. Hong, L.; Wang, X. C.; Zheng, H. Y.; He, L.; Wang, H.; Yu, H. Y.; RusliFemtosecond Laser Induced Nanocone Structure and Simultaneous Crystallization of 1.6 μM Amorphous Silicon Thin Film for Photovoltaic Application. J. Phys. D: Appl. Phys.2013, 46, 195109, 10.1088/0022-3727/46/19/195109
  37. Hong, L.; Wang, X.; Rusli; Wang, H.; Zheng, H.; Yu, H.Crystallization and Surface Texturing of Amorphous-Si Induced by UV Laser for Photovoltaic Application. J. Appl. Phys.2012, 111, 043106, 10.1063/1.3686612
  38. Magdi, S.; Swillam, M. A.Broadband Absorption Enhancement in Amorphous Si Solar Cells Using Metal Gratings and Surface Texturing. Proc. SPIE2017, 10099, 1009912, 10.1117/12.2253326
  39. Diedenhofen, S. L.; Janssen, O. T. A.; Grzela, G.; Bakkers, E. P. A. M.; Gómez Rivas, J.Strong Geometrical Dependence of the Absorption of Light in Arrays of Semiconductor Nanowires. ACS Nano2011, 5, 2316–2323, 10.1021/nn103596n
  40. Jäger, S. T.; Strehle, S.Design Parameters for Enhanced Photon Absorption in Vertically Aligned Silicon Nanowire Arrays. Nanoscale Res. Lett.2014, 9, 511, 10.1186/1556-276X-9-511
  41. Gouda, A. M.; Elsayed, M. Y.; Khalifa, A. E.; Ismail, Y.; Swillam, M. A.Lithography-Free Wide-Angle Antireflective Self-Cleaning Silicon Nanocones. Opt. Lett.2016, 41, 3575, 10.1364/OL.41.003575
  42. Magdi, S.; Swillam, M. A.Optical Analysis of Si-Tapered Nanowires/low Band Gap Polymer Hybrid Solar Cells. Proc. SPIE2017, 10099, 100991D, 10.1117/12.2253299
  43. Jiang, Y.; Gong, X.; Qin, R.; Liu, H.; Xia, C.; Ma, H.Efficiency Enhancement Mechanism for Poly(3, 4-ethylenedioxythiophene:Poly(styrenesulfonate/Silicon Nanowires Hybrid Solar Cells Using Alkali Treatment. Nanoscale Res. Lett.2016, 11, 267, 10.1186/s11671-016-1450-5
  44. Gong, X.; Jiang, Y.; Li, M.; Liu, H.; Ma, H.Hybrid Tapered Silicon nanowire/PEDOT:PSS Solar Cells. RSC Adv.2015, 5 (14, 10310–10317, 10.1039/C4RA16603E
  45. Mohammad, N. S.Understanding Quantum Confinement in Nanowires: Basics, Applications and Possible Laws. J. Phys.: Condens. Matter2014, 26, 423202, 10.1088/0953-8984/26/42/423202
  46. Zhang, A.; Luo, S.; Ouyang, G.; Yang, G. W.Strain-Induced Optical Absorption Properties of Semiconductor Nanocrystals. J. Chem. Phys.2013, 138, 244702, 10.1063/1.4811222
  47. He, Y.; Yu, W.; Ouyang, G.Shape-Dependent Conversion Efficiency of Si Nanowire Solar Cells with Polygonal Cross-Sections. J. Appl. Phys.2016, 119, 225101, 10.1063/1.4953377
  48. Tchakarov, S.; Das, D.; Saadane, O.; Kharchenko, A. V.; Suendo, V.; Kail, F.; Roca i Cabarrocas, P.Helium versus Hydrogen Dilution in the Optimization of Polymorphous Silicon Solar Cells. J. Non-Cryst. Solids2004, 338–340, 668–672, 10.1016/j.jnoncrysol.2004.03.068
  49. Roszairi, H.; Rahman, S. a.High Deposition Rate Thin Film Hydrogenated Amorphous Silicon Prepared by D.c. Plasma Enhanced Chemical Vapour Deposition of Helium Diluted Silane. IEEE International Conference on Semiconductor Electronics, 2002. Proceedings. ICSE 2002, Panang, Malaysia, Dec. 19–21, 2002; IEEE: New York, NY, USA, 2002; pp 300–303, DOI: 10.1109/SMELEC.2002.1217830.
  50. N’Guyen, T. T. T.; Duong, H. T. T.; Basuki, J.; Montembault, V.; Pascual, S.; Guibert, C.; Fresnais, J.; Boyer, C.; Whittaker, M. R.; Davis, T. P.; Fontaine, L.Functional Iron Oxide Magnetic Nanoparticles with Hyperthermia-Induced Drug Release Ability by Using a Combination of Orthogonal Click Reactions. Angew. Chem., Int. Ed.2013, 52, 14152–14156, 10.1002/anie.201306724
  51. Xu, Z.; Zhao, Y.; Wang, X.; Lin, T.A Thermally Healable Polyhedral Oligomeric Silsesquioxane (POSS Nanocomposite based on Diels-Alder chemistry. Chem. Commun.2013, 49, 6755–6757, 10.1039/c3cc43432j
  52. Engel, T.; Kickelbick, G.Self-Healing Nanocomposites from Silica – Polymer Core – Shell Nanoparticles. Polym. Int.2014, 63, 915–923, 10.1002/pi.4642
  53. Engel, T.; Kickelbick, G.Furan-Modified Spherosilicates as Building Blocks for Self-Healing Materials. Eur. J. Inorg. Chem.2015, 2015, 1226–1232, 10.1002/ejic.201402551
  54. Torres-Lugo, M.; Rinaldi, C.Thermal Potentiation of Chemotherapy by Magnetic Nanoparticles. nomedicine2013, 8, 1689–1707, 10.2217/nnm.13.146
  55. Hohlbein, N.; Shaaban, A.; Bras, A. R.; Pyckhout-Hintzen, W.; Schmidt, A. M.Self-healing Dynamic Bond-based Rubbers: Understanding the Mechanisms in Ionomeric Elastomer Model Systems. Phys. Chem. Chem. Phys.2015, 17, 21005–21017, 10.1039/C5CP00620A
  56. Wu, C.-S.; Kao, T.-H.; Li, H.-Y.; Liu, Y.-L.Preparation of Polybenzoxazine-functionalized Fe3O4 Nanoparticles through in situ Diels–Alder Polymerization for High Performance Magnetic Polybenzoxazine/Fe3O4 Nanocomposites. Compos. Sci. Technol.2012, 72, 1562–1567, 10.1016/j.compscitech.2012.06.018
  57. Menon, A. V.; Madras, G.; Bose, S.Ultrafast Self-Healable Interfaces in Polyurethane Nanocomposites Designed Using Diels–Alder “Click” as an Efficient Microwave Absorber. ACS Omega2018, 3, 1137–1146, 10.1021/acsomega.7b01845
  58. Engel, T.; Kickelbick, G.Thermoreversible Reactions on Inorganic Nanoparticle Surfaces: Diels–Alder Reactions on Sterically Crowded Surfaces. Chem. Mater.2013, 25, 149–157, 10.1021/cm303049k
  59. Schäfer, S.; Kickelbick, G.Self-Healing Polymer Nanocomposites based on Diels-Alder-reactions with Silica Nanoparticles: The Role of the Polymer Matrix. Polymer2015, 69, 357–368, 10.1016/j.polymer.2015.03.017
  60. Park, J. S.; Darlington, T.; Starr, A. F.; Takahashi, K.; Riendeau, J.; Thomas Hahn, H.Multiple Healing Effect of Thermally Activated Self-Healing Composites based on Diels–Alder reaction. Compos. Sci. Technol.2010, 70, 2154–2159, 10.1016/j.compscitech.2010.08.017
  61. Li, J.; Liang, J.; Li, L.; Ren, F.; Hu, W.; Li, J.; Qi, S.; Pei, Q.Healable Capacitive Touch Screen Sensors Based on Transparent Composite ElectrodesComprising Silver Nanowires and a Furan/Maleimide Diels-Alder Cycloaddition Polymer. ACS Nano2014, 8, 12874–12882, 10.1021/nn506610p
  62. Sun, S.; Zeng, H.; Robinson, D. B.; Raoux, S.; Rice, P. M.; Wang, S. X.; Li, G.Monodisperse MFe2O4 (M = Fe, Co, Mn Nanoparticles. J. Am. Chem. Soc.2004, 126, 273–279, 10.1021/ja0380852
  63. Frison, R.; Cernuto, G.; Cervellino, A.; Zaharko, O.; Colonna, G. M.; Guagliardi, A.; Masciocchi, N.Magnetite–Maghemite Nanoparticles in the 5–15 nm Range: Correlating the Core–Shell Composition and the Surface Structure to the Magnetic Properties. A Total Scattering Study. Chem. Mater.2013, 25, 4820–4827, 10.1021/cm403360f
  64. Santoyo Salazar, J.; Perez, L.; de Abril, O.; Truong Phuoc, L.; Ihiawakrim, D.; Vazquez, M.; Greneche, J.-M.; Begin-Colin, S.; Pourroy, G.Magnetic Iron Oxide Nanoparticles in 10–40 nm Range: Composition in Terms of Magnetite/Maghemite Ratio and Effect on the Magnetic Properties. Chem. Mater.2011, 23, 1379–1386, 10.1021/cm103188a
  65. Guerrero, G.; Mutin, P. H.; Vioux, A.Anchoring of Phosphonate and Phosphinate Coupling Molecules on Titania Particles. Chem. Mater.2001, 13, 4367–4373, 10.1021/cm001253u
  66. Babu, K.; Dhamodharan, R.Grafting of Poly(methyl methacrylate Brushes from Magnetite Nanoparticles Using a Phosphonic Acid Based Initiator by Ambient Temperature Atom Transfer Radical Polymerization (ATATRP. Nanoscale Res. Lett.2008, 3, 109–117, 10.1007/s11671-008-9121-9
  67. Mohapatra, S.; Pramanik, P.Synthesis and Stability of Functionalized Iron Oxide Nanoparticles using Organophosphorus Coupling Agents. Colloids Surf., A2009, 339, 35–42, 10.1016/j.colsurfa.2009.01.009
  68. Larsen, B. A.; Hurst, K. M.; Ashurst, W. R.; Serkova, N. J.; Stoldt, C. R.Mono- and Dialkoxysilane Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Application as Magnetic Resonance Imaging Contrast Agents. J. Mater. Res.2012, 27, 1846–1852, 10.1557/jmr.2012.160
  69. Davis, K.; Qi, B.; Witmer, M.; Kitchens, C. L.; Powell, B. A.; Mefford, O. T.Quantitative Measurement of Ligand Exchange on Iron Oxides via Radiolabeled Oleic Acid. Langmuir2014, 30, 10918–10925, 10.1021/la502204g
  70. Feichtenschlager, B.; Pabisch, S.; Peterlik, H.; Kickelbick, G.Nanoparticle Assemblies as Probes for Self-Assembled Monolayer Characterization: Correlation between Surface Functionalization and Agglomeration Behavior. Langmuir2012, 28, 741–750, 10.1021/la2023067
  71. Musa, O. M.Handbook of Maleic Anhydride Based Materials: Syntheses, Properties and Applications;Springer International Publishing: Switzerland, 2016; p 175ff.
  72. Sauer, R.; Froimowicz, P.; Scholler, K.; Cramer, J. M.; Ritz, S.; Mailander, V.; Landfester, K.Design, Synthesis, and Miniemulsion Polymerization of New Phosphonate Surfmers and Application Studies of the Resulting Nanoparticles as Model Systems for Biomimetic Mineralization and Cellular Uptake. Chem. - Eur. J.2012, 18, 5201–5212, 10.1002/chem.201103256
  73. Lu, C.; Bhatt, L. R.; Jun, H. Y.; Park, S. H.; Chai, K. Y.Carboxyl–Polyethylene Glycol–Phosphoric Acid: A Ligand for highly stabilized Iron Oxide Nanoparticles. J. Mater. Chem.2012, 22, 19806–19811, 10.1039/c2jm34327d
  74. Patsula, V.; Kosinova, L.; Lovric, M.; Ferhatovic Hamzic, L.; Rabyk, M.; Konefal, R.; Paruzel, A.; Slouf, M.; Herynek, V.; Gajovic, S.; Horak, D.Superparamagnetic Fe3O4 Nanoparticles: Synthesis by Thermal Decomposition of Iron(III Glucuronate and Application in Magnetic Resonance Imaging. ACS Appl. Mater. Interfaces2016, 8, 7238–7247, 10.1021/acsami.5b12720
  75. Pothayee, N.; Balasubramaniam, S.; Davis, R. M.; Riffle, J. S.; Carroll, M. R. J.; Woodward, R. C.; St Pierre, T. G.Synthesis of ‘ready-to-adsorb’ Polymeric Nanoshells for Magnetic Iron Oxide Nanoparticles via Atom Transfer Radical Polymerization. Polymer2011, 52, 1356–1366, 10.1016/j.polymer.2011.01.047
  76. Daou, J.; Begin-Colin, S.; Grenèche, J. M.; Thomas, F.; Derory, A.; Bernhardt, P.; Legaré, P.; Pourroy, G.Phosphate Adsorption Properties of Magnetite-Based Nanoparticles. Chem. Mater.2007, 19, 4494–4505, 10.1021/cm071046v
  77. Breucker, L.; Landfester, K.; Taden, A.Phosphonic Acid-Functionalized Polyurethane Dispersions with Improved Adhesion Properties. ACS Appl. Mater. Interfaces2015, 7, 24641–24648, 10.1021/acsami.5b06903
  78. Sahoo, Y.; Pizem, H.; Fried, T.; Golodnitsky, D.; Burstein, L.; Sukenik, C. N.; Markovich, G.Alkyl Phosphonate/Phosphate Coating on Magnetite Nanoparticles: A Comparison with Fatty Acids. Langmuir2001, 17, 7907–7911, 10.1021/la010703+
  79. Longo, R. C.; Cho, K.; Schmidt, W. G.; Chabal, Y. J.; Thissen, P.Monolayer Doping via Phosphonic Acid Grafting on Silicon: Microscopic Insight from Infrared Spectroscopy and Density Functional Theory Calculations. Adv. Funct. Mater.2013, 23, 3471–3477, 10.1002/adfm.201202808
  80. Luschtinetz, R.; Seifert, G.; Jaehne, E.; Adler, H.-J. P.Infrared Spectra of Alkylphosphonic Acid Bound to Aluminium Surfaces. Macromol. Symp.2007, 254, 248–253, 10.1002/masy.200750837
  81. Thomas, L. C.; Chittenden, R. A.Characteristic Infrared Absorption Frequencies of Organophosphorus Compounds-II. P-O-(X Bonds. Spectrochim. Acta1964, 20, 489–502, 10.1016/0371-1951(6480044-8
  82. Quinones, R.; Shoup, D.; Behnke, G.; Peck, C.; Agarwal, S.; Gupta, R. K.; Fagan, J. W.; Mueller, K. T.; Iuliucci, R. J.; Wang, Q.Study of Perfluorophosphonic Acid Surface Modifications on Zinc Oxide Nanoparticles. Materials2017, 10, 1–16, 10.3390/ma10121363
  83. Lalatonne, Y.; Paris, C.; Serfaty, J. M.; Weinmann, P.; Lecouvey, M.; Motte, L.Bis-Phosphonates-Ultra Small Superparamagnetic Iron Oxide Nanoparticles: A Platform towards Diagnosis and Therapy. Chem. Commun.2008, 2553–2555, 10.1039/b801911h
  84. Jastrzebski, W.; Sitarz, M.; Rokita, M.; Bulat, K.Infrared Spectroscopy of different Phosphates Structures. Spectrochim. Acta, Part A2011, 79, 722–727, 10.1016/j.saa.2010.08.044
  85. Brodard-Severac, F.; Guerrero, G.; Maquet, J.; Florian, P.; Gervais, C.; Mutin, P. H.High-Field 17O MAS NMR Investigation of Phosphonic Acid Monolayers on Titania. Chem. Mater.2008, 20, 5191–5196, 10.1021/cm8012683
  86. Brice-Profeta, S.; Arrio, M. A.; Tronc, E.; Menguy, N.; Letard, I.; CartierditMoulin, C.; Noguès, M.; Chanéac, C.; Jolivet, J. P.; Sainctavit, P.Magnetic Order in g-Fe2O3 Nanoparticles: A XMCD Study. J. Magn. Magn. Mater.2005, 288, 354–365, 10.1016/j.jmmm.2004.09.120
  87. Tronc, E.; Ezzir, A.; Cherkaoui, R.; Chanéac, C.; Noguès, M.; Kachkachi, H.; Fiorani, D.; Testa, A. M.; Grenèche, J. M.; Jolivet, J. P.Surface-Related Properties of g-Fe2O3 Nanoparticles. J. Magn. Magn. Mater.2000, 221, 63–79, 10.1016/S0304-8853(0000369-3
  88. Yee, C.; Kataby, G.; Ulman, A.; Prozorov, T.; White, H.; King, A.; Rafailovich, M.; Sokolov, J.; Gedanken, A.Self-Assembled Monolayers of Alkanesulfonic and -phosphonic Acids on Amorphous Iron Oxide Nanoparticles. Langmuir1999, 15, 7111–7115, 10.1021/la990663y
  89. Jolivet, J. P.; Chaneac, C.; Tronc, E.Iron Oxide Chemistry. From Molecular Clusters to Extended Solid Networks. Chem. Commun.2004, 481–487, 10.1039/B304532N
  90. Campbell, V. E.; Tonelli, M.; Cimatti, I.; Moussy, J. B.; Tortech, L.; Dappe, Y. J.; Riviere, E.; Guillot, R.; Delprat, S.; Mattana, R.; Seneor, P.; Ohresser, P.; Choueikani, F.; Otero, E.; Koprowiak, F.; Chilkuri, V. G.; Suaud, N.; Guihery, N.; Galtayries, A.; Miserque, F.; Arrio, M. A.; Sainctavit, P.; Mallah, T.Engineering the Magnetic Coupling and Anisotropy at the Molecule-Magnetic Surface Interface in Molecular Spintronic Devices. Nat. Commun.2016, 7, 13646–10, 10.1038/ncomms13646
  91. Pabisiak, T.; Winiarski, M. J.; Ossowski, T.; Kiejna, A.Adsorption of Gold Subnano-Structures on a Magnetite (111 Surface and their Interaction with CO. Phys. Chem. Chem. Phys.2016, 18, 18169–18179, 10.1039/C6CP03222B
  92. Gomes, R.; Hassinen, A.; Szczygiel, A.; Zhao, Q.; Vantomme, A.; Martins, J. C.; Hens, Z.Binding of Phosphonic Acids to CdSe Quantum Dots: A Solution NMR Study. J. Phys. Chem. Lett.2011, 2, 145–152, 10.1021/jz1016729
  93. Chun, Y.-J.; Park, J.-N.; Oh, G.-M.; Hong, S.-I.; Kim, Y.-J.Synthesis of ω-Phthalimidoalkylphosphonates. Synthesis1994, 1994, 909–910, 10.1055/s-1994-25599
  94. A. Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO Nanoparticles for Eliminating Cancer Cells”, J Nanomed Res., Volume 2, Issue 5, 20 Pages, 2015.
  95. A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III Oxide (Rh2O3 Nanoparticles”, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Issue 1, Pages 15–19, 2015.
  96. A. Heidari, “An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility”, Int J Adv Technol 7: e007, 2016.
  97. A. Heidari, “Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study”, J Pharmacogn Nat Prod 2: e103, 2016.
  98. A. Heidari, “A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexes”, J Bioeng Biomed Sci S: 006, 2016.
  99. A. Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
  100. A. Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol Res Ther 5: e146, 2016.
  101. A. Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT for Cancer Cells”, J Bioanal Biomed 8: e135, 2016.
  102. A. Heidari, “A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells”, Adv Cancer Prev 1: e102, 2016.
  103. A. Heidari, “Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO and Rhodium (III Oxide (Rh2O3 Nanoparticles”, J Biotechnol Biomater 6: e125, 2016.
  104. A. Heidari, “A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study”, J Res Development 4: 144, 2016.
  105. A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol 5: e146, 2016.
  106. A. Heidari, “Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Study”, Arch Cancer Res. 4: 1, 2016.
  107. A. Heidari, “Biospectroscopic Study on Multi–Component Reactions (MCRs in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs”, Arch Cancer Res. 4: 2, 2016.
  108. A. Heidari, “Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd: YAG Lasers”, Arch Cancer Res. 4: 2, 2016.
  109. A. Heidari, “Quantitative Structure–Activity Relationship (QSAR Approximation for Cadmium Oxide (CdO and Rhodium (III Oxide (Rh2O3 Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res. 4: 1, 2016.
  110. A. Heidari, “Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles”, J Biomedical Sci. 5: 2, 2016.
  111. A. Heidari, “Measurement the Amount of Vitamin D2 (Ergocalciferol, Vitamin D3 (Cholecalciferol and Absorbable Calcium (Ca2+, Iron (II (Fe2+, Magnesium (Mg2+, Phosphate (PO4– and Zinc (Zn2+ in Apricot Using High–Performance Liquid Chromatography (HPLC and Spectroscopic Techniques”, J Biom Biostat 7: 292, 2016.
  112. A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+, Neon Dimer (Ne2+, Argon Dimer (Ar2+, Krypton Dimer (Kr2+, Xenon Dimer (Xe2+, Radon Dimer(Rn2+ and Ununoctium Dimer (Uuo2+ Molecular Cations”, Chem Sci J 7: e112, 2016.
  113. A. Heidari, “Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques”, J Drug Metab Toxicol 7: e129, 2016.
  114. A. Heidari, “Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO Nanoparticles as Anti–Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatment”, Biochem Pharmacol (Los Angel 5: 207, 2016.
  115. A. Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs, Amorphous Boron Nitride Nanotubes (a–BNNTs and Hexagonal Boron Nitride Nanotubes (h–BNNTs as Hydrogen Storage”, Struct Chem Crystallogr Commun 2: 1, 2016.
  116. A. Heidari, “Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells”, Pharm Anal Chem Open Access 2: 113, 2016.
  117. A. Heidari, “A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO and Rhodium (III Oxide (Rh2O3 Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment”, Chemo Open Access 5: e129, 2016.
  118. A. Heidari, “Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications”, J Pharmacokinet Exp Ther 1: e005, 2016.
  119. A. Heidari, “Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques”, Insights Anal Electrochem 2: 1, 2016.
  120. A. Heidari, “Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP Type Using a Set of Topological Descriptors”, J Heavy Met Toxicity Dis. 1: 2, 2016.
  121. A. Heidari, “Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016.
  122. A. Heidari, “A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Study”, Transl Biomed. 7: 2, 2016.
  123. A. Heidari, “Ab Initio and Density Functional Theory (DFT Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic Discov 6: e144, 2016.
  124. A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol 5: e111, 2016.
  125. A. Heidari, “Synthesis and Study of 5–(PhenylsulfonylAmino–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques”, Transl Med (Sunnyvale 6: e138, 2016.
  126. A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3 Using Soave–Redlich–Kwong (SRK and Pang–Robinson (PR Equations”, Electronic J Biol 12: 4, 2016.
  127. A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3 (1: 1058, 2016.
  128. A. Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016.
  129. A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International Journal of Advanced Chemistry, 4 (1 5–9, 2016.
  130. A. Heidari, “Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues”, Arch Can Res. 4: 2, 2016.
  131. A. Heidari, “Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS Drugs”, J Data Mining Genomics & Proteomics 7: e125, 2016.
  132. A. Heidari, “Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5 Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cells”, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016.
  133. A. Heidari, “Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approach”, Transl Biomed. 7: 2, 2016.
  134. A. Heidari, “A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP Method”, Arch Can Res. 4: 2, 2016.
  135. A. Heidari, Cheminformatics and System Chemistry of Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs: A Combined Computational and Experimental Study”, J Inform Data Min 1: 3, 2016.
  136. A. Heidari, “Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR Study of Hydrous Ruthenium (IV Oxide (RuO2 Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs and Anti–Cancer Nano Drugs”, J Integr Oncol 5: e110, 2016.
  137. A. Heidari, “Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method”, J Nanosci Curr Res 1: e101, 2016.
  138. A. Heidari, “Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drug”, Int J Drug Dev & Res 8: 007–008, 2016.
  139. A. Heidari, “A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic Retention Relationships (QSRR Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”, J Pharmacovigil 4: e161, 2016.
  140. A. Heidari, Nanotechnology in Preparation of Semipermeable Polymers, J Adv Chem Eng 6: 157, 2016.
  141. A. Heidari, “A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic Retention Relationships (QSRR Models for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
  142. A. Heidari, “DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives”, Biomedical Data Mining 5: e102, 2016.
  143. A. Heidari, “A Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR and Quantitative Structure–Property Relationship (QSPR under Synchrotron Radiations Using Genetic Function Approximation (GFA Algorithm, J Mol Biol Biotechnol 1: 1, 2016.
  144. A. Heidari, “Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
  145. A. Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB Boron Nitride Nanotubes (BNNTs, Amorphous Boron Nitride Nanotubes (a–BNNTs and Hexagonal Boron Nitride Nanotubes (h–BNNTs”, J Appl Computat Math 5: e143, 2016.
  146. A. Heidari, “The Impact of High Resolution Imaging on Diagnosis”, Int J Clin Med Imaging 3: 1000e101, 2016.
  147. A. Heidari, “A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid and Tretinoin (All–Trans Retinoic Acid (ATRA Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF and Density Functional Theory (DFT Methods”, Insights in Biomed 1: 2, 2016.
  148. A. Heidari, “Advances in Logic, Operations and Computational Mathematics”, J Appl Computat Math 5: 5, 2016.
  149. A. Heidari, “Mathematical Equations in Predicting Physical Behavior”, J Appl Computat Math 5: 5, 2016.
  150. A. Heidari, “Chemotherapy a Last Resort for Cancer Treatment”, Chemo Open Access 5: 4, 2016.
  151. A. Heidari, “Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV Synchrotron Radiation and Various Analytical Methods”, Mass Spectrom Purif Tech 2: e101, 2016.
  152. A. Heidari, “Yoctosecond Quantitative Structure–Activity Relationship (QSAR and Quantitative Structure–Property Relationship (QSPR under Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA Algorithm”, Insight Pharm Res. 1: 1, 2016.
  153. A. Heidari, “Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR and Quantitative Structure Properties Relationship (QSPR Studies”, Int J Clin Med Imaging 3: 516, 2016.
  154. A. Heidari, “A Novel Approach to Biology”, Electronic J Biol 12: 4, 2016.
  155. A. Heidari, “Innovative Biomedical Equipment’s for Diagnosis and Treatment”, J Bioengineer & Biomedical Sci 6: 2, 2016.
  156. A. Heidari, “Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends in Oncology Medicine and Practices”, J Oncol Med & Pract 1: 2, 2016.
  157. A. Heidari, “Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectives”, J Bioengineer & Biomedical Sci 6: 3, 2016.
  158. A. Heidari, “X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container
    Design”
    , J Powder Metall Min 6: 1, 2017.
  159. A. Heidari, “Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective”, Arch Chem Res. 1: 2, 2017.
  160. A. Heidari, “Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis: Number of Mutations in a Synchronous Tumor Varies by Age and Type of Synchronous Cancer”, J Appl Bioinforma Comput Biol, 6: 1, 2017.
  161. A. Heidari, “Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs as Qubits for Quantum Computing”, Glob J Res Rev. 4: 2, 2017.
  162. A. Heidari, Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation of Au38–xAgx/xCux(SPh–tBu24 to Au36–xAgx/xCux(SPh–tBu24 (x = 1–12 Nanomolecules for Synthesis of Au144–xAgx/xCux(SR60, (SC460, (SC660, (SC1260, (PET60, (p–MBA60, (F60, (Cl60, (Br60, (I60, (At60, (Uus60 and (SC6H1360 Nano Clusters as Anti–Cancer Nano Drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017.
  163. A. Heidari, “Biomedical Resource Oncology and Data Mining to
    Enable Resource Discovery in Medical, Medicinal, Clinical, Pharmaceutical,
    Chemical and Translational Research and Their Applications in Cancer Research”
    ,
    Int J Biomed Data Min 6: e103, 2017.
  164. A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing,
    Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for
    Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy,
    Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”
    , J Dev Drugs 6: e154, 2017.
  165. A. Heidari, “A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV, Tuberculosis (TB, Microbiome/Antibiotic Resistance and Endovascular Stroke”, J Bioengineer & Biomedical Sci 7: e127, 2017.
  166. A. Heidari, “Opinion on Computational Fluid Dynamics (CFD
    Technique”
    , Fluid Mech Open Acc 4: 157, 2017.
  167. A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS Treatment Using Magnetic Resonance Imaging (MRI and Au329(SR84, Au329–xAgx(SR84, Au144(SR60, Au68(SR36, Au30(SR18, Au102(SPh44, Au38(SPh24, Au38(SC2H4Ph24, Au21S(SAdm15, Au36(pMBA24 and Au25(pMBA18 Nano Clusters”, J Surgery Emerg Med
    1: 21, 2017.
  168. A. Heidari, Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy”, Cell Biol (Henderson, NV 6: 1, 2017.
  169. A. Heidari, “Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors”, J Powder Metall Min 6: 170, 2017.
  170. A. Heidari, “Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti–Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation”, Am J Drug Deliv 5: 2, 2017.
  171. A. Heidari, “Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression”, J Biol Med Science 1: e103, 2017.
  172. A. Heidari, “The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Delivery”, Br Biomed Bull 5: 305, 2017.
  173. A. Heidari,  “Integrative Approach to Biological Networks for Emerging Roles of Proteomics, Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiation”, Transcriptomics 5: e117, 2017.
  174. A. Heidari, “Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiation”, Lett Health Biol Sci 2 (2: 1–4, 2017.
  175. A. Heidari, “Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs Coated with Nano Graphene Oxide (GO and Protonated Polyaniline (PANI in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiation”, Br J Res, 4 (3: 16, 2017.
  176. A. Heidari, “Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidity”, Res Rep Gastroenterol, 1: 1, 2017.
  177. A. Heidari, “Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to Prevent Cardiovascular Disease under Synchrotron Radiation”, J Pharm Sci Emerg Drugs 5: 1, 2017.
  178. A. Heidari, “Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeams”, J Cell Biol Mol Sci 2 (1: 1–5, 2017.
  179. A. Heidari, “Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiation”, J Nanotechnol Material Sci 4 (2: 1–5, 2017.
  180. R. Gobato, A. Heidari, “Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSi”, Science Journal of Analytical Chemistry, Vol. 5, No. 6, Pages 76–85, 2017.
  181. A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Med Oncol. Vol. 1 No. 1: 1, 2017.
  182. A. Heidari, “A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation”,   Am J Ethnomed, Vol. 4 No. 1: 10, 2017.
  183. A. Heidari, “Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV Nanocarriers under Synchrotron Radiation”, J Med Chem Toxicol, 2 (3: 1–5, 2017.
  184. A. Heidari, Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin, Norethindrone (NET, Norethisterone Acetate (NETA, Norethisterone Enanthate (NETE and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment”, Parana Journal of Science and Education (PJSE–v.3, n.4, (10–19 October 12, 2017.
  185. A. Heidari, “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”, Open J Anal Bioanal Chem 1 (1: 014–020, 2017.
  186. A. Heidari, “Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity”, Enz Eng 6: 1, 2017.
  187. A. Heidari, “Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS”, Mod Appro Drug Des. 1 (1. MADD.000504. 2017.
  188. A. Heidari, “Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells”, J Proteomics Enzymol 6: 1, 2017.
  189. A. Heidari, “Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation”, J Pharm Pharmaceutics 4 (2: 1–5, 2017.
  190. A. Heidari, C. Brown, “Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G, Fluoxetine Hydrochloride (Prozac and Sarafem, Propofol (Diprivan, Acetylsalicylic Acid (ASA (Aspirin, Naproxen Sodium (Aleve and Naprosyn and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems”, Ann Adv Chem. 1 (2: 061–069, 2017.
  191. A. Heidari, “High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation”, J Transl Res. 1 (1: 1–3, 2017.
  192. 192 A. Heidari, “Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica”, Current Trends Anal Bioanal Chem, 1 (1: 36–41, 2017.
  193. A. Heidari, “Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle Using Synchrotron Radiation”, Arch Biotechnol Biomed. 1 (1: 067–0100, 2017.
  194. A. Heidari, “Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiation”, SOJ Mater Sci Eng 5 (2: 1–6, 2017.
  195. A. Heidari, “Cavity Ring–Down Spectroscopy (CRDS, Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Challenges Cancer Detect Ther 4 (2: e001, 2017.
  196. A. Heidari, “Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Hepatol Gastroenterol, 3 (4: 079–084, 2017.
  197. A. Heidari, “Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Pharmacovigilance and Drug Safety 4 (2: e001, 2017.
  198. A. Heidari, “Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiation”, Open J Anal Bioanal Chem 1 (1: 021–026, 2017.
  199. A. Heidari, “Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR Spectroscopy and Electron Spin Resonance (ESR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Austin J Anal Pharm Chem. 4 (3: 1091, 2017.
  200. A. Heidari, “Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLAB”, Madridge J Nano Tech. Sci. 2 (2: 77–83, 2017.
  201. A. Heidari, “A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancers”, Cancer Clin Res Rep, 1: 2,  e001, 2017.
  202. A. Heidari, “A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiation”, Cancer Sci Res Open Access 4 (2: 1–8, 2017.
  203. A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Oral Cancer Res 1 (1: 12–17, 2017.
  204. A. Heidari, “Vibrational Decihertz (dHz, Centihertz (cHz, Millihertz (mHz, Microhertz (μHz, Nanohertz (nHz, Picohertz (pHz, Femtohertz (fHz, Attohertz (aHz, Zeptohertz (zHz and Yoctohertz (yHz Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, International Journal of Biomedicine, 7 (4, 335–340, 2017.
  205. A. Heidari, “Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, EC Cancer, 2 (5, 239–246, 2017.
  206. A. Heidari, “Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, BAOJ Cancer Res Ther, 3: 3, 045–052, 2017.
  207. A. Heidari, “J–Spectroscopy, Exchange Spectroscopy (EXSY, Nucle­ar Overhauser Effect Spectroscopy (NOESY and Total Correlation Spectroscopy (TOCSY Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Eng Sci J, 1 (2: 006–013, 2017.
  208. A. Heidari, “Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Biopharm Sci, 1: 103–107, 2017.
  209. A. Heidari, “Vibrational Decahertz (daHz, Hectohertz (hHz, Kilohertz (kHz, Megahertz (MHz, Gigahertz (GHz, Terahertz (THz, Petahertz (PHz, Exahertz (EHz, Zettahertz (ZHz and Yottahertz (YHz Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Madridge J Anal Sci Instrum, 2 (1: 41–46, 2017.
  210. 2A. Heidari, “Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Mater Sci Nanotechnol 6 (1: 101, 2018.
  211. A. Heidari, “Fourier Transform Infrared (FTIR Spectroscopy, Near–Infrared Spectroscopy (NIRS and Mid–Infrared Spectroscopy (MIRS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6, 2018.
  212. A. Heidari, “Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Austin Pharmacol Pharm, 3 (1: 1011, 2018.
  213. A. Heidari, “Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulation”, Madridge J Nov Drug Res, 1 (1: 18–24, 2017.
  214. A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Open Access J Trans Med Res, 2 (1: 00026–00032, 2018.
  215. M. R. R. Gobato, R. Gobato, A. Heidari, “Planting of Jaboticaba Trees for Landscape Repair of Degraded Area”, Landscape Architecture and Regional Planning, Vol. 3, No. 1, 2018, Pages 1–9, 2018.
  216. A. Heidari, “Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, SM J Clin. Med. Imaging, 4 (1: 1018, 2018.
  217. A. Heidari, “Nuclear Inelastic Scattering Spectroscopy (NISS and Nuclear Inelastic Absorption Spectroscopy (NIAS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Pharm Sci, 2 (1: 1–14, 2018.
  218. A. Heidari, “X–Ray Diffraction (XRD, Powder X–Ray Diffraction (PXRD and Energy–Dispersive X–Ray Diffraction (EDXRD Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Oncol Res; 2 (1: 1–14, 2018.
  219. A. Heidari, “Correlation Two–Dimensional Nuclear Magnetic Reso­nance (NMR (2D–NMR (COSY Imaging and Spectrosco­py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Can Sci, 1–1–001, 2018.
  220. A. Heidari, “Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, SM J Biometrics Biostat, 3 (1: 1024, 2018.
  221. A. Heidari, “A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’ Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy”, Open Acc J Oncol Med. 1 (1, 2018.
  222. A. Heidari, “Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC, Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiation”, J Endocrinol Thyroid Res, 3 (1: 555603, 2018.
  223. A. Heidari, “Nuclear Resonance Vibrational Spectroscopy (NRVS, Nuclear Inelastic Scattering Spectroscopy (NISS, Nuclear Inelastic Absorption Spectroscopy (NIAS and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (1e: 1–5, 2018.
  224. A. Heidari, “A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiation”, Glob J Endocrinol Metab. 1 (3. GJEM. 000514–000519, 2018.
  225. A. Heidari, “Pros and Cons Controversy on Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC, Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Pharma J. 1 (1: 002–008, 2018.
  226. A. Heidari, “A Modern Comparative and Comprehensive Experimental Biospectroscopic Study on Different Types of Infrared Spectroscopy of Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, J Analyt Molecul Tech. 3 (1: 8, 2018.
  227. A. Heidari, “Investigation of Cancer Types Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, European Modern Studies Journal, Vol. 2, No. 1, 13–29, 2018.
  228. A. Heidari, “Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Imaging J Clin Medical Sci. 5 (1: 001–007, 2018.
  229. A. Heidari, “Small–Angle Neutron Scattering (SANS and Wide–Angle X–Ray Diffraction (WAXD Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (2e: 1–6, 2018.
  230. A. Heidari, “Investigation of Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver, Lung Cancer, Melanoma, Non–Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer and Non–Melanoma Skin Cancer Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, Ther Res Skin Dis 1 (1, 2018.
  231. A. Heidari, “Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR Spectroscopy and Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, International Journal of Chemistry Papers, 2 (1: 1–12, 2018.
  232. A. Heidari, “Mössbauer Spectroscopy, Mössbauer Emission Spectroscopy and 57Fe Mössbauer Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Cancer Biology 2.3: 17–20, 2018.
  233. A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Organic & Medicinal Chem IJ. 6 (1: 555676, 2018.
  234. A. Heidari, “Correlation Spectroscopy, Exclusive Correlation Spectroscopy and Total Correlation Spectroscopy Comparative Study on Malignant and Benign Human AIDS–Related Cancers Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Bioanal Biomed. 2 (1: 001–007, 2018.
  235. A. Heidari, “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Delivery”, Am J Nanotechnol Nanomed. 1 (1: 001–009, 2018.
  236. A. Heidari, “Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Ann Biomet Biostat. 1 (1: 1001, 2018.
  237. 237 A. Heidari, “Grazing–Incidence Small–Angle Neutron Scattering (GISANS and Grazing–Incidence X–Ray Diffraction (GIXD Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron Radiation”, Ann Cardiovasc Surg. 1 (2: 1006, 2018.
  238. A. Heidari, “Adsorption Isotherms and Kinetics of Multi–Walled Carbon Nanotubes (MWCNTs, Boron Nitride Nanotubes (BNNTs, Amorphous Boron Nitride Nanotubes (a–BNNTs and Hexagonal Boron Nitride Nanotubes (h–BNNTs for Eliminating Carcinoma, Sarcoma, Lymphoma, Leukemia, Germ Cell Tumor and Blastoma Cancer Cells and Tissues”, Clin Med Rev Case Rep 5: 201, 2018.
  239. A. Heidari, “Correlation Spectroscopy (COSY, Exclusive Correlation Spectroscopy (ECOSY, Total Correlation Spectroscopy (TOCSY, Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE, Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC, Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC, Nuclear Overhauser Effect Spectroscopy (NOESY and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Pharmaceutical Sciences 2.5: 30–35, 2018.
  240. A. Heidari, “Small–Angle X–Ray Scattering (SAXS, Ultra–Small Angle X–Ray Scattering (USAXS, Fluctuation X–Ray Scattering (FXS, Wide–Angle X–Ray Scattering (WAXS, Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS, Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS, Small–Angle Neutron Scattering (SANS, Grazing–Incidence Small–Angle Neutron Scattering (GISANS, X–Ray Diffraction (XRD, Powder X–Ray Diffraction (PXRD, Wide–Angle X–Ray Diffraction (WAXD, Grazing–Incidence X–Ray Diffraction (GIXD and Energy–Dispersive X–Ray Diffraction (EDXRD Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Oncol Res Rev, Volume 1 (1: 1–10, 2018.
  241. A. Heidari, “Pump–Probe Spectroscopy and Transient Grating Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Adv Material Sci Engg, Volume 2,  Issue 1, Pages 1–7, 2018.
  242. A. Heidari, “Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS and Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Insights Pharmacol Pharm Sci 1 (1: 1–8, 2018.
  243. A. Heidari, “Acoustic Spectroscopy, Acoustic Resonance Spectroscopy and Auger Spectroscopy Comparative Study on Anti–Cancer Nano Drugs Delivery in Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Nanosci Technol 5 (1: 1–9, 2018.
  244. A. Heidari, “Niobium, Technetium, Ruthenium, Rhodium, Hafnium, Rhenium, Osmium and Iridium Ions Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Nanomed Nanotechnol, 3 (2: 000138, 2018.
  245. A. Heidari, “Homonuclear Correlation Experiments such as Homonuclear Single–Quantum Correlation Spectroscopy (HSQC, Homonuclear Multiple–Quantum Correlation Spectroscopy (HMQC and Homonuclear Multiple–Bond Correlation Spectroscopy (HMBC Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Austin J Proteomics Bioinform & Genomics. 5 (1: 1024, 2018.
  246. A. Heidari, “Atomic Force Microscopy Based Infrared (AFM–IR Spectroscopy and Nuclear Resonance Vibrational Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Appl Biotechnol Bioeng. 5 (3: 142‒148, 2018.
  247. A. Heidari, “Time–Dependent Vibrational Spectral Analysis of Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Cancer Oncol, 2 (2: 000124, 2018.
  248. A. Heidari, “Palauamine and Olympiadane Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Arc Org Inorg Chem Sci 3 (1, 2018.
  249. R. Gobato, A. Heidari, “Infrared Spectrum and Sites of Action of Sanguinarine by Molecular Mechanics and ab initio Methods”, International Journal of Atmospheric and Oceanic Sciences. Vol. 2, No. 1, pp. 1–9, 2018.
  250. A. Heidari, “Angelic Acid, Diabolic Acids, Draculin and Miraculin Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment Under Synchrotron and Synchrocyclotron Radiations”, Med & Analy Chem Int J, 2 (1: 000111, 2018.
  251. A. Heidari, “Gamma Linolenic Methyl Ester, 5–Heptadeca–5,8,11–Trienyl 1,3,4–Oxadiazole–2–Thiol, Sulphoquinovosyl Diacyl Glycerol, Ruscogenin, Nocturnoside B, Protodioscine B, Parquisoside–B, Leiocarposide, Narangenin, 7–Methoxy Hespertin, Lupeol, Rosemariquinone, Rosmanol and Rosemadiol Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Int J Pharma Anal Acta, 2 (1: 007–014, 2018.
  252. A. Heidari, “Fourier Transform Infrared (FTIR Spectroscopy, Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR Spectroscopy, Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR Spectroscopy, Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy, Non–Linear Two–Dimensional Infrared Spectroscopy, Atomic Force Microscopy Based Infrared (AFM–IR Spectroscopy, Infrared Photodissociation Spectroscopy, Infrared Correlation Table Spectroscopy, Near–Infrared Spectroscopy (NIRS, Mid–Infrared Spectroscopy (MIRS, Nuclear Resonance Vibrational Spectroscopy, Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (2: 1–14, 2018.
  253. A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations”, Chronicle of Medicine and Surgery 2.3: 144–156, 2018.
  254. A. Heidari, “Tetrakis 3, 5–bis (Trifluoromethyl Phenyl Borate (BARF–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Medical Research and Clinical Case Reports 2.1: 113–126, 2018.
  255. A. Heidari, “Sydnone, Münchnone, Montréalone, Mogone, Montelukast, Quebecol and Palau’amine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Sur Cas Stud Op Acc J. 1 (3, 2018.
  256. A. Heidari, “Fornacite, Orotic Acid, Rhamnetin, Sodium Ethyl Xanthate (SEX and Spermine (Spermidine or Polyamine Nanomolecules Incorporation into the Nanopolymeric Matrix (NPM”, International Journal of Biochemistry and Biomolecules, Vol. 4: Issue 1, Pages 1–19, 2018.
  257. A. Heidari, R. Gobato, “Putrescine, Cadaverine, Spermine and Spermidine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Parana Journal of Science and Education (PJSE–v.4, n.5, (1–14 July 1, 2018.
  258. A. Heidari, “Cadaverine (1,5–Pentanediamine or Pentamethylenediamine, Diethyl Azodicarboxylate (DEAD or DEADCAT and Putrescine (Tetramethylenediamine Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Hiv and Sexual Health Open Access Open Journal. 1 (1: 4–11, 2018.
  259. A. Heidari, “Improving the Performance of Nano–Endofullerenes in Polyaniline Nanostructure–Based Biosensors by Covering Californium Colloidal Nanoparticles with Multi–Walled Carbon Nanotubes”, Journal of Advances in Nanomaterials, Vol. 3, No. 1, Pages 1–28, 2018.
  260. R. Gobato, A. Heidari, “Molecular Mechanics and Quantum Chemical Study on Sites of Action of Sanguinarine Using Vibrational Spectroscopy Based on Molecular Mechanics and Quantum Chemical Calculations”, Malaysian Journal of Chemistry, Vol. 20 (1, 1–23, 2018.
  261. A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part I”, Malaysian Journal of Chemistry, Vol. 20 (1, 33–73, 2018.
  262. A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part II”, Malaysian Journal of Chemistry, Vol. 20 (1, 74–117, 2018.
  263. A. Heidari, “Uranocene (U(C8H82 and Bis(CyclooctatetraeneIron (Fe(C8H82 or Fe(COT2–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Chemistry Reports, Vol. 1, Iss. 2, Pages 1–16, 2018.
  264. A. Heidari, “Biomedical Systematic and Emerging Technological Study on Human Malignant and Benign Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (3: 1–7, 2018.
  265. A. Heidari, “Deep–Level Transient Spectroscopy and X–Ray Photoelectron Spectroscopy (XPS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Res Dev Material Sci. 7(2. RDMS.000659, 2018.
  266. A. Heidari, “C70–Carboxyfullerenes Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”,  Glob Imaging Insights, Volume 3 (3: 1–7, 2018.
  267. A. Heidari, “The Effect of Temperature on Cadmium Oxide (CdO Nanoparticles Produced by Synchrotron Radiation in the Human Cancer Cells, Tissues and Tumors”, International Journal of Advanced Chemistry, 6 (2 140–156, 2018.
  268. A. Heidari, “A Clinical and Molecular Pathology Investigation of Correlation Spectroscopy (COSY, Exclusive Correlation Spectroscopy (ECOSY, Total Correlation Spectroscopy (TOCSY, Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations Using Cyclotron versus Synchrotron, Synchrocyclotron and the Large Hadron Collider (LHC for Delivery of Proton and Helium Ion (Charged Particle Beams for Oncology Radiotherapy”, European Journal of Advances in Engineering and Technology, 5 (7: 414–426, 2018.
  269. A. Heidari, “Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, J Oncol Res; 1 (1: 1–20, 2018.
  270. A. Heidari, “Use of Molecular Enzymes in the Treatment of Chronic Disorders”, Canc Oncol Open Access J. 1 (1: 12–15, 2018.
  271. A. Heidari, “Vibrational Biospectroscopic Study and Chemical Structure Analysis of Unsaturated Polyamides Nanoparticles as Anti–Cancer Polymeric Nanomedicines Using Synchrotron Radiation”, International Journal of Advanced Chemistry, 6 (2, 167–189, 2018.
  272. A. Heidari, “Adamantane, Irene, Naftazone and Pyridine–Enhanced Precatalyst Preparation Stabilization and Initiation (PEPPSI Nano Molecules”, Madridge J Nov Drug Res. 2 (1: 61–67, 2018.
  273. A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Madridge J Nov Drug Res, 2 (1: 68–74, 2018.
  274. A. Heidari, R. Gobato, “A Novel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNA of Human Cancer Cells–Containing Cocaine (Coke, Lysergide (Lysergic Acid Diethyl Amide or LSD, Δ⁹–Tetrahydrocannabinol (THC (––trans–Δ⁹–Tetrahydrocannabinol, Theobromine (Xantheose, Caffeine, Aspartame (APM (NutraSweet and Zidovudine (ZDV Azidothymidine (AZT as Anti–Cancer Nano Drugs by Coassembly of Dual Anti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistance”, Parana Journal of Science and Education, v. 4, n. 6, pp. 1–17, 2018.
  275. A. Heidari, R. Gobato, “Ultraviolet Photoelectron Spectroscopy (UPS and Ultraviolet–Visible (UV–Vis Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Parana Journal of Science and Education, v. 4, n. 6, pp. 18–33, 2018.
  276. R. Gobato, A. Heidari, A. Mitra, “The Creation of C13H20BeLi2SeSi. The Proposal of a Bio–Inorganic Molecule, Using Ab Initio Methods for the Genesis of a Nano Membrane”, Arc Org Inorg Chem Sci 3 (4. AOICS.MS.ID.000167, 2018.
  277. R. Gobato, A. Heidari, A. Mitra, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, ResearchGate, See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/326201181, 2018.
  278. R. Gobato, A. Heidari, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, J Nanomed Res.7 (4: 241‒252, 2018.
  279. A. Heidari, “Bastadins and Bastaranes–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Glob Imaging Insights, Volume 3 (4: 1–7, 2018.
  280. A. Heidari, “Fucitol, Pterodactyladiene, DEAD or DEADCAT (DiEthyl AzoDiCArboxylaTe, Skatole, the NanoPutians, Thebacon, Pikachurin, Tie Fighter, Spermidine and Mirasorvone Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4: 1–8, 2018.
  281. E. Dadvar, A. Heidari, “A Review on Separation Techniques of Graphene Oxide (GO/Base on Hybrid Polymer Membranes for Eradication of Dyes and Oil Compounds: Recent Progress in Graphene Oxide (GO/Base on Polymer Membranes–Related Nanotechnologies”, Clin Med Rev Case Rep 5: 228, 2018.
  282. A. Heidari, R. Gobato, “First–Time Simulation of Deoxyuridine Monophosphate (dUMP (Deoxyuridylic Acid or Deoxyuridylate and Vomitoxin (Deoxynivalenol (DON ((3α,7α–3,7,15–Trihydroxy–12,13–Epoxytrichothec–9–En–8–One–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Parana Journal of Science and Education, Vol. 4, No. 6, pp. 46–67, 2018.
  283. A. Heidari, “Buckminsterfullerene (Fullerene, Bullvalene, Dickite and Josiphos Ligands Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Hematology and Thromboembolic Diseases Prevention, Diagnosis and Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4: 1–7, 2018.
  284. A. Heidari, “Fluctuation X–Ray Scattering (FXS and Wide–Angle X–Ray Scattering (WAXS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (4: 1–7, 2018.
  285. A. Heidari, “A Novel Approach to Correlation Spectroscopy (COSY, Exclusive Correlation Spectroscopy (ECOSY, Total Correlation Spectroscopy (TOCSY, Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE, Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC, Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC, Nuclear Overhauser Effect Spectroscopy (NOESY and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5: 1–9, 2018.
  286. A. Heidari, Terphenyl–Based Reversible Receptor with Rhodamine, Rhodamine–Based Molecular Probe, Rhodamine–Based Using the Spirolactam Ring Opening, Rhodamine B with Ferrocene Substituent, Calix4Arene–Based Receptor, Thioether + Aniline–Derived Ligand Framework Linked to a Fluorescein Platform, Mercuryfluor–1 (Flourescent Probe, N,N’–Dibenzyl–1,4,10,13–Tetraraoxa–7,16–Diazacyclooctadecane and Terphenyl–Based Reversible Receptor with Pyrene and Quinoline as the Fluorophores–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Glob Imaging Insights, Volume 3 (5: 1–9, 2018.
  287. A. Heidari, “Small–Angle X–Ray Scattering (SAXS, Ultra–Small Angle X–Ray Scattering (USAXS, Fluctuation X–Ray Scattering (FXS, Wide–Angle X–Ray Scattering (WAXS, Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS, Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS, Small–Angle Neutron Scattering (SANS, Grazing–Incidence Small–Angle Neutron Scattering (GISANS, X–Ray Diffraction (XRD, Powder X–Ray Diffraction (PXRD, Wide–Angle X–Ray Diffraction (WAXD, Grazing–Incidence X–Ray Diffraction (GIXD and Energy–Dispersive X–Ray Diffraction (EDXRD Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5: 1–10, 2018.
  288. A. Heidari, “Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS and Nuclear Resonance Vibrational Spectroscopy (NRVS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation, Glob Imaging Insights, Volume 3 (5: 1–7, 2018.
  289. A. Heidari, “Small–Angle X–Ray Scattering (SAXS and Ultra–Small Angle X–Ray Scattering (USAXS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5: 1–7, 2018.
  290. A. Heidari, “Curious Chloride (CmCl3 and Titanic Chloride (TiCl4–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules for Cancer Treatment and Cellular Therapeutics”, J. Cancer Research and Therapeutic Interventions, Volume 1, Issue 1, Pages 01–10, 2018.
  291. R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd”, Arc Org Inorg Chem Sci 3 (5, Pages 402–409, 2018.
  292. A. Heidari, “C60 and C70–Encapsulating Carbon Nanotubes Incorporation into the Nano Polymeric Matrix (NPM by Immersion of the Nano Polymeric Modified Electrode (NPME as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Integr Mol Med, Volume 5 (3: 1–8, 2018.
  293. A. Heidari, “Two–Dimensional (2D 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6: 1–8, 2018.
  294. A. Heidari, “FT–Raman Spectroscopy, Coherent Anti–Stokes Raman Spectroscopy (CARS and Raman Optical Activity Spectroscopy (ROAS Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6: 1–8, 2018.
  295. A. Heidari, “A Modern and Comprehensive Investigation of Inelastic Electron Tunneling Spectroscopy (IETS and Scanning Tunneling Spectroscopy on Malignant and Benign Human Cancer Cells, Tissues and Tumors through Optimizing Synchrotron Microbeam Radiotherapy for Human Cancer Treatments and Diagnostics: An Experimental Biospectroscopic Comparative Study”, Glob Imaging Insights, Volume 3 (6: 1–8, 2018.
  296. A. Heidari, “A Hypertension Approach to Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6: 1–8, 2018.
  297. A. Heidari, “Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE, Nuclear Overhauser Effect Spectroscopy (NOESY and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6: 1–8, 2018.
  298. A. Heidari, “2–Amino–9–((1S, 3R, 4R–4–Hydroxy–3–(Hydroxymethyl–2–Methylenecyclopentyl–1H–Purin–6(9H–One, 2–Amino–9–((1R, 3R, 4R–4–Hydroxy–3–(Hydroxymethyl–2–Methylenecyclopentyl–1H–Purin–6(9H–One, 2–Amino–9–((1R, 3R, 4S–4–Hydroxy–3–(Hydroxymethyl–2–Methylenecyclopentyl–1H–Purin–6(9H–One and 2–Amino–9–((1S, 3R, 4S–4–Hydroxy–3–(Hydroxymethyl–2–Methylenecyclopentyl–1H–Purin–6(9H–One–Enhanced Precatalyst Preparation Stabilization and Initiation Nano Molecules”, Glob Imaging Insights, Volume 3 (6: 1–9, 2018.
  299. R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd”, American Journal of Quantum Chemistry and Molecular Spectroscopy, Vol. 2, No. 1, pp. 9–17, 2018.
  300. A. Heidari, “Production of Electrochemiluminescence (ECL Biosensor Using Os–Pd/HfC Nanocomposites for Detecting and Tracking of Human Gastroenterological Cancer Cells, Tissues and Tumors”, Int J Med Nano Res 5: 1, 022–034, 2018.
  301. A. Heidari, “Enhancing the Raman Scattering for Diagnosis and Treatment of Human Cancer Cells, Tissues and Tumors Using Cadmium Oxide (CdO Nanoparticles”, J Toxicol Risk Assess 4: 1, 012–025, 2018.
  302. A. Heidari, “Human Malignant and Benign Human Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation Using Anti–Cancer Nano Drugs Delivery”, Integr Mol Med, Volume 5 (5: 1–13, 2018.
  303. A. Heidari, Analogous Nano Compounds of the Form M(C8H82 Exist for M = (Nd, Tb, Pu, Pa, Np, Th, and Yb–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI Nano Molecules”, Integr Mol Med, Volume 5 (5: 1–8, 2018.
  304. A. Heidari, “Hadron Spectroscopy, Baryon Spectroscopy and Meson Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Integr Mol Med, Volume 5 (5: 1–8, 2018.
  305. R. Gobato, M. R. R. Gobato, A. Heidari, “Raman Spectroscopy Study of the Nano Molecule C13H20BeLi2SeSi Using ab initio and Hartree–Fock Methods in the Basis Set CC–pVTZ and 6–311G** (3df, 3pd”, International Journal of Advanced Engineering and Science, Volume 7, Number 1, Pages 14–35, 2019.
  306. A. Heidari, R. Gobato, “Evaluating the Effect of Anti–Cancer Nano Drugs Dosage and Reduced Leukemia and Polycythemia Vera Levels on Trend of the Human Blood and Bone Marrow Cancers under Synchrotron Radiation”, Trends in Res, Volume 2 (1: 1–8, 2019.
  307. A. Heidari, R. Gobato, “Assessing the Variety of Synchrotron, Synchrocyclotron and LASER Radiations and Their Roles and Applications in Human Cancer Cells, Tissues and Tumors Diagnosis and Treatment”, Trends in Res, Volume 2 (1: 1–8, 2019.
  308. A. Heidari, R. Gobato, “Pros and Cons Controversy on Malignant Human Cancer Cells, Tissues and Tumors Transformation Process to Benign Human Cancer Cells, Tissues and Tumors”, Trends in Res, Volume 2 (1: 1–8, 2019.
  309. A. Heidari, R. Gobato, “Three–Dimensional (3D Simulations of Human Cancer Cells, Tissues and Tumors for Using in Human Cancer Cells, Tissues and Tumors Diagnosis and Treatment as a Powerful Tool in Human Cancer Cells, Tissues and Tumors Research and Anti–Cancer Nano Drugs Sensitivity and Delivery Area Discovery and Evaluation”, Trends in Res, Volume 2 (1: 1–8, 2019.
  310. A. Heidari, R. Gobato, “Investigation of Energy Production by Synchrotron, Synchrocyclotron and LASER Radiations in Human Cancer Cells, Tissues and Tumors and Evaluation of Their Effective on Human Cancer Cells, Tissues and Tumors Treatment Trend”, Trends in Res, Volume 2 (1: 1–8, 2019.
  311. A. Heidari, R. Gobato, “High–Resolution Mapping of DNA/RNA Hypermethylation and Hypomethylation Process in Human Cancer Cells, Tissues and Tumors under Synchrotron Radiation”, Trends in Res, Volume 2 (2: 1–9, 2019.
  312. A. Heidari, “A Novel and Comprehensive Study on Manufacturing and Fabrication Nanoparticles Methods and Techniques for Processing Cadmium Oxide (CdO Nanoparticles Colloidal Solution”, Glob Imaging Insights, Volume 4 (1: 1–8, 2019.
  313. A. Heidari, “A Combined Experimental and Computational Study on the Catalytic Effect of Aluminum Nitride Nanocrystal (AlN on the Polymerization of Benzene, Naphthalene, Anthracene, Phenanthrene, Chrysene and Tetracene”, Glob Imaging Insights, Volume 4 (1: 1–8, 2019.
  314. A. Heidari, “Novel Experimental and Three–Dimensional (3D Multiphysics Computational Framework of Michaelis–Menten Kinetics for Catalyst Processes Innovation, Characterization and Carrier Applications”, Glob Imaging Insights, Volume 4 (1: 1–8, 2019.
  315. A. Heidari, “The Hydrolysis Constants of Copper (I (Cu+ and Copper (II (Cu2+ in Aqueous Solution as a Function of pH Using a Combination of pH Measurement and Biospectroscopic Methods and Techniques”, Glob Imaging Insights, Volume 4 (1: 1–8, 2019.
  316. A. Heidari, “Vibrational Biospectroscopic Study of Ginormous Virus–Sized Macromolecule and Polypeptide Macromolecule as Mega Macromolecules Using Attenuated Total Reflectance–Fourier Transform Infrared (ATR–FTIR Spectroscopy and Mathematica 11.3”, Glob Imaging Insights, Volume 4 (1: 1–8, 2019.
  317. A. Heidari, “Three–Dimensional (3D Imaging Spectroscopy of Carcinoma, Sarcoma, Leukemia, Lymphoma, Multiple Myeloma, Melanoma, Brain and Spinal Cord Tumors, Germ Cell Tumors, Neuroendocrine Tumors and Carcinoid Tumors under Synchrotron Radiation”, Glob Imaging Insights, Volume 4 (1: 1–9, 2019.
  318. R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “New Nano–Molecule Kurumi–C13H 20BeLi2SeSi/C13H19BeLi2SeSi, and Raman Spectroscopy Using ab initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G** (3df, 3pd”, J Anal Pharm Res. 8 (1: 1‒6, 2019.
  319. A. Heidari, J. Esposito, A. Caissutti, “The Importance of Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR and Raman Biospectroscopy of Single–Walled Carbon Nanotubes (SWCNT and Multi–Walled Carbon Nanotubes (MWCNT in Interpreting Infrared and Raman Spectra of Human Cancer Cells, Tissues and Tumors”, Oncogen 2 (2: 1–21, 2019.
  320. A. Heidari, J. Esposito, A. Caissutti, “Study of Anti–Cancer Properties of Thin Layers of Cadmium Oxide (CdO Nanostructure”, Int J Analyt Bioanalyt Methods 1 (1, 20 Pages, 2019.
  321. A Heidari, J Esposito, A Caissutti, “The Quantum Entanglement Dynamics Induced by Non-Linear Interaction between a Moving Nano Molecule and a Two-Mode Field with Two-Photon Transitions Using Reduced Von Neumann Entropy and Jaynes-Cummings Model for Human Cancer Cells, Tissues and Tumors Diagnosis”, Int J Crit Care Emerg Med 5 (2: 071–084, 2019.
  322. A. Heidari, “Mechanism of Action and Their Side Effects at a Glance Prevention, Treatment and Management of Immune System and Human Cancer Nano Chemotherapy”, Nanosci Technol 6 (1: 1–4, 2019.
  323. R. Gobato, MRR. Gobato, A. Heidari, “Evidence of Tornado Storm Hit the Counties of Rio Branco do Ivaí and Rosario de Ivaí, Southern Brazil”, Sci Lett 7 (1, 9 Pages, 2019.
  324. A. Heidari, J. Esposito, A. Caissutti, “The Importance of Quantum Hydrodynamics (QHD Approach to Single–Walled Carbon Nanotubes (SWCNT and Multi–Walled Carbon Nanotubes (MWCNT in Genetic Science”, SCIOL Genet Sci 2 (1: 113–129, 2019.
  325. A. Heidari, J. Esposito, A. Caissutti, “Palytoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, J Pharm Drug Res, 3 (1: 150–170, 2019.
  326. A. Heidari, J. Esposito, A. Caissutti, “Aplysiatoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, J J Chem Sci Eng, 2 (2: 70–89, 2019.
  327. A. Heidari, J. Esposito, A. Caissutti, “Cyanotoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, British Journal of Medical and Health Research, 6 (4: 1–41, 2019.
  328. A. Heidari, “Potential and Theranostics Applications of Novel Anti–Cancer Nano Drugs Delivery Systems in Preparing for Clinical Trials of Synchrotron Microbeam Radiation Therapy (SMRT and Synchrotron Stereotactic Radiotherapy (SSRT for Treatment of Human Cancer Cells, Tissues and Tumors Using Image Guided Synchrotron Radiotherapy (IGSR”, Ann Nanosci Nanotechnol, 3 (1: 1006–1019, 2019.
  329. A. Heidari, “Clinical and Medical Pros and Cons of Human Cancer Cells’ Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy Process under Synchrotron Radiation: A Case Study on Mechanism of Action and Their Side Effects”, Parana Journal of Science and Education, Vol. 5, No. 3, pp. 1–23, 2019.
  330. A. Heidari, “The Importance of the Power in CMOS Inverter Circuit of Synchrotron and Synchrocyclotron Radiations Using 50 (nm and 100 (nm Technologies and Reducing the Voltage of Power Supply”, Radiother Oncol Int, 1 (1: 1002–1015, 2019.
  331. R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi Via Quantum Chemistry Using Ab initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G** (3df, 3pd”, American Journal of Quantum Chemistry and Molecular Spectroscopy. Vol. 2, No. 1, pp. 9–17, 2018.
  332. A. Heidari, J. Esposito, A. Caissutti, “Anatoxin–a and Anatoxin–a(s Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Saudi J Biomed Res, 4 (4: 174–194, 2019.
  333. A. Heidari, J. Esposito, A. Caissutti, “Alpha–Conotoxin, Omega–Conotoxin and Mu–Conotoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, International Journal of Advanced Chemistry, 7 (1: 52–66, 2019.
  334. A. Heidari, J. Esposito, A. Caissutti, “Shiga–Like Toxin (SLT Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Annal Biostat & Biomed Appli. 2(3: 2019. ABBA.MS.ID.000537. DOI: 10.33552/ABBA.2019.02.000537.
  335. A. Heidari, J. Esposito, A. Caissutti, “Alpha–Bungarotoxin, Beta–Bungarotoxin and Kappa–Bungarotoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Archives of Pharmacology and Pharmaceutical Sciences, ReDelve: RD–PHA–10001, 2019.
  336. A. Heidari, “Investigation of the Processes of Absorption, Distribution, Metabolism and Elimination (ADME as Vital and Important Factors for Modulating Drug Action and Toxicity”, Open Access J Oncol 2019, 2 (1: 180010.
  337. A. Heidari, J. Esposito, A. Caissutti, “Okadaic Acid Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Int J Analyt Bioanalyt Methods 1: 004, 2019.
  338. A. Heidari, J. Esposito, A. Caissutti, “Pertussis Toxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Chemistry Reports, Vol. 1 Iss. 2, Pages 1–5, 2019.
  339. R. Gobato, M. R. R. Gobato, A. Heidari, “Rhodochrosite as Crystal Oscillator”, Am J Biomed Sci & Res. 3 (2, 187, 2019.
  340. A. Heidari, J. Esposito, A. Caissutti, “Tetrodotoxin (TTX Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Journal of New Developments in Chemistry, Volume No: 2, Issue No: 3, Page Numbers 26–48, 2019.
  341. A. Heidari, J. Esposito, A. Caissutti, “The Importance of Analysis of Vibronic–Mode Coupling Structure in Vibration­al Spectra of Supramolecular Aggregates of (CA*M Cyanuric Acid (CA and Melamine (M beyond the Franck–Condon Approximation”, Journal of Clinical and Medical Images, 2 (2: 1–20, 2019.
  342. A. Heidari, J. Esposito, A. Caissutti, “Spider Toxin and Raventoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Parana Journal of Science and Education. Vol. 5, No. 4, pp. 1–28, 2019.
  343. A. Heidari, J. Esposito, A. Caissutti, “Microcystin–LR Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Malaysian Journal of Chemistry, Vol. 21 (1, 70–95, 2019.
  344. A. Heidari, J. Esposito, A. Caissutti, “Botulinum Toxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Journal of Mechanical Design and Vibration, vol. 7, no. 1: 1–15, 2019.
  345. A. Heidari, J. Esposito, A. Caissutti, "Domoic Acid (DA Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis", Cientific Clinical Oncology Journal 1. 2: 03–07, 2019.
  346. A. Heidari, J. Esposito, A. Caissutti, "Surugatoxin (SGTX Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis", Cientific Clinical Oncology Journal 1. 2: 14–18, 2019.
  347. A. Heidari, J. Esposito, A. Caissutti, "Decarbamoylsaxitoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis", Cientific Clinical Oncology Journal 1. 2: 19–23, 2019.
  348. A. Heidari, J. Esposito, A. Caissutti, "Gonyautoxin (GTX Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis", Cientific Clinical Oncology Journal 1. 2: 24–28, 2019.
  349. A. Heidari, J. Esposito, A. Caissutti, "Hislrionicotoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis", Cientific Drug Delivery Research 1. 1: 01–06, 2019.
  350. A. Heidari, J. Esposito, A. Caissutti, “Dihydrokainic Acid Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 1: 07–12, 2019.
  351. A. Heidari, J. Esposito, A. Caissutti, “Aflatoxin B1 (AFB1, B2 (AFB2, G1 (AFG1, G2 (AFG2, M1 (AFM1, M2 (AFM2, Q1 (AFQ1 and P1 (AFP1 Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 1: 25–32, 2019.
  352. A. Heidari, J. Esposito, A. Caissutti, “Mycotoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 1: 13–18, 2019.
  353. A. Heidari, J. Esposito, A. Caissutti, “Bufotoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 1: 19–24, 2019.
  354. A. Heidari, J. Esposito, A. Caissutti, “Kainic Acid (Kainite Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Journal of Neurology 1. 2: 02–07, 2019.
  355. A. Heidari, J. Esposito, A. Caissutti, “Nereistoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Journal of Neurology 1. 2: 19–24, 2019.
  356. A. Heidari, J. Esposito, A. Caissutti, “Ochratoxin A, Ochratoxin B, Ochratoxin C, Ochratoxin α and Ochratoxin TA Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 2: 03–10, 2019.
  357. A. Heidari, J. Esposito, A. Caissutti, “Brevetoxin A and B Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 2: 11–16, 2019.
  358. A. Heidari, J. Esposito, A. Caissutti, “Lyngbyatoxin–a Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Drug Delivery Research 1. 2: 23–28, 2019.
  359. A. Heidari, J. Esposito, A. Caissutti, “Balraechotoxin (BTX Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Cientific Journal of Neurology 1. 3: 01–05, 2019.
  360. A. Heidari, J. Esposito, A. Caissutti, “Hanatoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Int. J. Pharm. Sci. Rev. Res., 57 (1, Pages: 21–32, 2019.
  361. A. Heidari, J. Esposito, A. Caissutti, “Neurotoxin and Alpha–Neurotoxin Time– Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, J Biomed Sci & Res. 3 (6, 550–563, 2019.
  362. A. Heidari, J. Esposito, A. Caissutti, “Antillatoxin (ATX Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT Investigation of Vibronic–Mode Coupling Structure”, American Journal of Optics and Photonics. Vol. 7, No. 1, pp. 18–27, 2019.
  363. R. Gobato, M. R. R. Gobato, A. Heidari, “Calculation by UFF Method of Frequencies and Vibrational Temperatures of the Unit Cell of the Rhodochrosite Crystal”, International Journal of Advanced Chemistry, 7 (2 77–81, 2019.
  364. A. Heidari, J. Esposito, A. Caissutti, “Analysis of Vibronic–Mode Coupling Structure in Vibrational Spectra of Fuzeon as a 36 Amino Acid Peptide for HIV Therapy beyond the Multi–Dimensional Franck–Condon Integrals Approximation”, International Journal of Advanced Chemistry, 7 (2 82–96, 2019.

Editorial Information

Editor-in-Chief

Ryota Mashiko
Fukui Medical University

Article Type

Image Article

Publication history

Received date: June 07, 2019
Accepted date: June 24, 2019
Published date: June 26, 2019

Copyright

© 2019 Heidari A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Heidari A, Esposito J, Caissutti A (2019) 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol Time-Resolved Absorption and Resonance FT-IR and Raman Biospectroscopy and Density Functional Theory (DFT) Investigation of Vibronic-Mode Coupling Structure in Vibrational Spectra Analysis. Clin Case Studie Rep 4: DOI: 10.15761/CCSR.1000126

Corresponding author

Alireza Heidari

Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Figure 1. Different sections of the extensive two-dimensional hydrogen bond network in a 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4- Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol [43-93]

Figure 2. 3D Simulation of (a) FT-IR spectrum and (b) Raman spectrum of 6-Methoxy-8-[[6-Methoxy-8-[[6-Methoxy-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-yl]Oxy]-2-Methyl-1-(2-Methylpropyl)-3,4-Dihydro-1H-Isoquinolin-7-ol